Screening and management of hepatitis B and C is quickly evolving. Local providers should be familiar with hepatitis B and C screening recommendations and reporting requirements.
Providers must report all suspected acute cases of hepatitis B and C.
There is no laboratory test that distinguishes acute from chronic hepatitis C. The NYC Department of Health relies on providers to report new cases of suspected acute hepatitis C. Providers do not need to report chronic hepatitis B and C.
You must report patients who:
Hepatitis C can be cured in almost all patients, including those who use drugs.
You should order a hepatitis C antibody test for any patient who is at risk of hepatitis C, including anyone who was born between 1945 and 1965. If a test is positive, you should also conduct a test for viral RNA to assess the patient’s infection status.
As of October 2017, laboratories performing hepatitis C testing for New York City residents are required to use an automatic confirmatory hepatitis C viral test for all positive hepatitis C antibody results (PDF).
If your patient is infected with hepatitis C, you should provide treatment, as well as:
If you cannot provide treatment to a patient with hepatitis C, you should refer them to a provider who manages hepatitis C.
You should screen any patient with risk factors for hepatitis B, as well as all anyone who was born in a country where hepatitis B prevalence is 2% or higher. You should also screen patients with hepatitis B surface antibody and surface antigen tests.
You should offer a hepatitis B vaccination to all at-risk adults who are not immune and any adult who would like to be vaccinated.
If your patient is infected with hepatitis B, you should:
If you cannot provide an assessment and treatment to a patient with hepatitis B, you should refer them to a provider who manages hepatitis B.